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Twelve-month old mice were shown to be appreciably more resistant than 3 month old mice to the development of tumours from subthreshold numbers of B16 tumour cells.
In mice injected with threshold amounts of the B16 tumour, there was no change in any of the responses in the tumour-free period, but there was a decrease in NK activity and an increase in cytostatic activity when a large tumour mass developed. An increase in the titre of natural antibodies in young mice injected with the tumour was also seen. The correlation between these changes and tumour appearance and development is discussed.
It is well established that aging individuals suffer from a decline in their natural as well as adaptive immune functions (Haughton & Whitmore, 1978; Makinodan & Kay, 1980; Tyan, 1981) . The concurrence of decreased immune reactivity and the high incidence of tumours in old individuals raises the possibility that the deterioration of the general immune status is causally related to the increased risk of developing spontaneous neoplasms with advanced age (Keast, 1970) .
The decline in immune vigour may be due to active suppressor mechanisms or to a passive deterioration of the immune system. Some forms of immunological decline can be restored by adoptive transfer into old animals of immunocytes from young ones (Makinodan & Kay, 1980) . In most cases however, spontaneous tumour development in old animals was not inhibited or delayed by administration of immune competent cells from young donors.
Mediators of natural immunity (NK/NC cells) (Stutman et al., 1980) , macrophages (Keller, 1980) and natural antibodies (Chow et al., 1981) are often postulated to function in tumour surveillance by constituting a first line of defence against the progression of newly transformed clones.
While certain expressions of natural cellular immunity such as NK activity decline with aging (Herberman & Holden, 1978) , the titre of naturally occurring anti tumour antibodies (NATA) frequently increases with age (Colnaghi et al., 1979; Witz et al., in press ). The decline in NK activity in mice over the age of 6 months may contribute to the enhanced growth of certain transplanted tumours in such mice (Haller et al., 1977) . Enhanced tumour growth can also be brought about by increased NATA titres .
In a study performed in our laboratory a population of splenocytes exhibiting cytostasis of NK-resistant tumour targets was described (Ehrlich et al., 1981) . This immunocyte population, which may play a role in keeping transformed cells in a dormant state, appears in mice at a very early age (10 days) .
The major goal of this study was to determine whether any of these 3 natural defence activities (NK cells, cytostatic cells and NATA) undergoes alterations in mice during the growth of transplanted tumours. In order to meet this goal we carried out a time course study in which we followed these three expressions of natural cellular and humoral activities in 3 month and in 12 month old mice inoculated with threshold numbers of cells from the transplanted B16 melanoma. Such a time course study has allowed us to determine whether one ( The YAC-1 cell culture (Cikes, 1973) (Fisher & Welch, 1957) , is a lymphoma of spontaneous origin passaged in syngeneic DBA/2 mice; YAC (Klein & Klein, 1964) , is a Moloney virus induced lymphoma passaged in A/St mice and RL6'1 (Sando et al., 1975) , is a radiation induced lymphoma passaged in BALB/c mice.
Fixation of tumour cells Cells were harvested from monolayer cultures using EDTA-trypsin; from suspension cultures or from 7 day old ascitic tumours (Moav et al., 1982 (Nisonoff et al., 1961) .
Iodination of Fab2Gc,MFab lodination with 1251 (Radiochemical Centre, Amersham, U.K.) was carried out by using the lodogen method (Fraker & Speck, 1978) .
Radioimmunobinding assay A solid phase radioimmunobinding assay was performed essentially according to the procedure described by Huang et al. (1975 NK activity NK activity mediated by splenocytes was measured by the 4 h or 18 h 51Cr release assay using YAC-l cells as targets. The assay was performed as described previously (Ehrlich et al., 1980 ). = z_-Cytostasis Cytostatic activity mediated by splenocytes was determined by the 125IUdR-incorporation-inhibition assay as described previously (Ehrlich et al., 1981 Figure 1 shows that there was a significant decline in NK activity (P<0.05 in Student's t test) in 12 month old mice. However, the NK activity of old mice could be apparently stimulated during prolonged incubation periods with the target cells. Due to this in vitro stimulation, it could be often seen that when using the 18 h 5'Cr release assay the differences between 3 and 12 month old animals was not so pronounced.
In contrast to the decline in NK activity the cytostatic activity did not alter with age ( Figure 1) . Figure 2 summarizes the results of a representative radioimmunobinding assay measuring the levels of NATA in 3 and 12 month old normal C57BL/6 mice. The sera from these mice were assayed for their ability to bind to a panel composed of several allogeneic tumour cells representing "public" target determinants (Witz et al., 1976; Klein et al., 1979) . Sera from 12 month old mice showed a higher binding activity to the tumour targets tested, compared to sera from 3 month old mice. This was consistent using different serum samples in 6 different binding experiments.
B16 melanoma development in 3 and 12 month old mice In the first set of experiments we compared the growth of B16 tumours in 3 and 12 month old syngeneic mice, inoculated s.c. with a subthreshold dose (104cells/mouse) of tumour cells. Figure 3 shows that B16 tumours grew better in the 3 month than in the 12 month old mice:
(1) The tumours appeared earlier in the younger mice (P<0.001 in Logrank test (Peto et al., 1977) .
(2) The tumour incidence was significantly higher in the younger mice (54/54) than in the older mice (39/54 = 61 %).
(3) The growth rate of the tumours was faster in the younger group.
The difference between the growth of these tumours in 3 and 12 month old mice diminished to a great extent when a higher dose of tumour cells (1O cells/mouse) was inoculated (Figure 4 ). '% A^ However, even under these circumstances it can be seen that the younger mice support the growth of the B16 melanoma (Fidler, 1973) better than the 12 month old animals. Natural defence in 3 and 12 month old mice inoculated with B16 cells In these experiments we compared natural defence mechanisms in 3 and 12 month old mice developing B16 tumours or tumours derived from its low (B16-FI) or high (B16-F10) metastasis variants.
Experimental design
We first determined (Figure 4) 'The '25IUDR incorporation-inhibition assay was performed on B16-FIO melanoma cells as targets.
(1) Three month old mice bearing B16-Fl or B16-F10 tumours had cytostatic and NK activities similar to those of untreated control mice;
(2) Twelve month old mice bearing B16-Fl tumours also had NK and cytostatic activities similar to age matched controls; (3) In contrast to these results 12 month old mice bearing the high metastasis B16-F1O tumours had a significant (P <0.05 in Student's t-test) decrease in their NK activity and a significant increase in their cytostatic activity. The increase in cytostasis (with B16-F1O cells as targets) can be interpreted either as an induced specific adaptive cellular activity against this syngeneic tumour or as a general increase in cytostasis.
Significant changes in cytotoxic and cytostatic activities were seen in 3 month old mice bearing s.c. B16 tumours or metastasis variants of this tumour in the abdominal region (Table II) . In these mice, the NK activity markedly decreased and the cytostatic activity inereased.
NATA in 3 and 12 month old C57BL/6 mice inoculated with high or low B16 metastasis variants The sera of 3 or 12 month old mice inoculated with B16-F1 or with B16-FIO tumours or normal age matched controls were assayed for their ability to bind to formalin fixed B16 tumour cells. Tumourbearer sera were assayed at various time intervals after tumour inoculation. The results of 2 experiments represented in Figure 5 show that sera from 3 month old B16-F1O inoculated but not from B16-Fl inoculated mice (28 or 
Discussion
Three and 12 month old C57BL/6 mice differ in their ability to resist the development of tumours from a subthreshold number of syngeneic transplantable B16 melanoma cells. Some of the older mice resisted tumour growth whereas all the younger ones succumbed to their tumours. A similar phenomenon was seen when skin cancers were induced in mice by U.V. irradiation (Ebbessen & Kripke, 1982) and in mice exposed to certain chemical carcinogens (Stutman, 1975) . In these cases tumour incidence, size and growth rate were lower in the older mice. In apparent contrast to these results are observations that tumour growth is enhanced in old animals (Stutman, 1975) . For example, certain transplanted lymphoma lines grow faster in old mice than in young mice (Haller et al., 1977) . It is therefore clear that no general rules can be formulated at present as to the effect of aging on the growth of induced or transplantable tumours.
It has already been proposed by Talmadge et al. (1980) that NK activity controls the outgrowth of inoculated B16 melanomas only if the cells comprising the inoculum are sensitive to NKmediated lysis. The B16 cells utilized in our laboratory are resistant to lysis mediated by NK cells (Ehrlich et al., 1981 (Hanna & Fidler, 1981; Hanna & Burton, 1981) .
The results obtained in this study demonstrate also that older mice differ from younger ones in two additional respects: (1) Normal 12 month old mice have higher titres of NATA than younger animals against certain tumour targets; (2) Three month old mice inoculated with highly metastatic B16-FIO cells (but without palpable tumours) have anti B16 antibodies while similarly treated 12 month old mice have none. These phenomena could be responsible for the enhanced growth of B16 tumours in the younger mice. For instance, it is not unlikely that the increased NATA levels in 12 month old mice retard the proliferation of tumour cells in these mice. On the other hand, the high antibody titre to B16 cells in 3 month old B16 bearing mice possibly an adaptive response to antigens expressed on the tumour (Baniyash et al., 1982) could facilitate the escape of tumour cells from destructive effectors and thus enhance tumour growth .
We could not detect any alteration in any of the expressions of natural immunity (i.e. NK, cytostasis and NATA) during the tumour latency period. The decreased NK activity observed in some tumour bearers could thus be a result of the presence of a large tumour rather than its cause.
